EMBL – Wellcome Connecting Science Conference: Proteomics in cell biology and disease mechanisms

This conference will take place at EMBL Heidelberg, with the option to attend virtually. Please see EMBL’s COVID-19 safety policy for testing and other requirements if attending the on-site event.

Conference Overview

Even after a few decades of great accomplishments, the field of proteomics remains to develop further, fueled by continued technological and computational advances in high-throughput methods and multi-omics big data integration. The Proteomics in Cell Biology and Disease Mechanisms conference will provide attendees with a program that provides the current “state-of-affairs” in proteomics including a future perspective. It will be held at a pioneering hot spot for proteomics in Europe, in association with EMBL, in Heidelberg Germany.

This year’s programme will focus on the latest technological advances with a focus on medical and clinical applications of proteomics, and fundamental and mechanistic aspects of cell biology including intra- and inter-cellular communication through interactions and post-translational modifications.

This is a cross-disciplinary meeting that will bring together proteomics technology experts of all ages, from academia and industry, life science specialists, and medical communities who are interested in systems biology, cell signalling, as well as disease and clinical proteomics.

EMBL Heidelberg will be hosting the final event of this very successful series that has been alternating between Heidelberg, Germany and Wellcome Genome Campus, UK.

Session Topics

• Cellular communication and Interactions
• Proteomics technologies
• Hot now: Single cells and spatial proteomics/li>
• Proteomics for precision medicine
• Computational proteomics and data analysis
• Post translational modifications

Deadlines

AUG 08:   Abstract Submission
SEP 13:       Registration (On-site)
OCT 18:     Registration (Virtual)

On-site Registration   |   Virtual Registration

 
#EWCSProteomics